Literature DB >> 16141712

Idiopathic pulmonary fibrosis: evaluation with positron emission tomography.

Horst-Helmut Meissner1, Guy W Soo Hoo, S Ali Khonsary, Mark Mandelkern, Charles V Brown, Silverio M Santiago.   

Abstract

BACKGROUND: The pathogenesis of interstitial lung disease remains under investigation, but may be related to increased inflammatory or cellular activity. This activity may be detectable with physiologic imaging.
OBJECTIVES: We investigated the role of physiologic imaging using (18)F-2-fluoro-2-deoxy-D-glucose ((18)FDG)-positron emission tomography (PET) scans in idiopathic pulmonary fibrosis (IPF).
METHODS: Seven male patients with histologically confirmed IPF underwent (18)FDG-PET scans. Scans were analyzed qualitatively and interpreted as positive or negative. Patients also underwent pulmonary function tests and computed tomography (CT) scans.
RESULTS: The average total lung capacity was 71 +/- 22% predicted (mean +/- SD) and diffusing capacity for carbon monoxide was 44 +/- 14% predicted. All had changes consistent with IPF on chest CT and 2 patients had ground glass attenuation. Six of seven patients (86%) had a positive (18)FDG-PET scan. Changes in the (18)FDG-PET scan were seen in 1 patient corresponding to changes in clinical status.
CONCLUSIONS: Our findings suggest that (18)FDG-PET scans may be helpful in the evaluation of IPF. Increased activity suggests active disease and changes in response to therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141712     DOI: 10.1159/000088062

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  15 in total

1.  Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia.

Authors:  Yukihiro Umeda; Yoshiki Demura; Takeshi Ishizaki; Shingo Ameshima; Isamu Miyamori; Yuji Saito; Tatsuro Tsuchida; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-27       Impact factor: 9.236

2.  The importance of correction for tissue fraction effects in lung PET: preliminary findings.

Authors:  Tryphon Lambrou; Ashley M Groves; Kjell Erlandsson; Nick Screaton; Raymondo Endozo; Thida Win; Joanna C Porter; Brian F Hutton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-27       Impact factor: 9.236

Review 3.  Mapping COVID-19 functional sequelae: the perspective of nuclear medicine.

Authors:  Simone Cristina Soares Brandão; Júlia de Oliveira Xavier Ramos; Gustavo Freitas Alves de Arruda; Emmanuelle Tenório Albuquerque Madruga Godoi; Lara Cristiane Terra Ferreira Carreira; Rafael Willain Lopes; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

4.  Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.

Authors:  Tomohiro Maniwa; Masahiro Endo; Mitsuhiro Isaka; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Haruhiko Kondo
Journal:  Surg Today       Date:  2013-09-05       Impact factor: 2.549

5.  18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials.

Authors:  Thida Win; Tryphon Lambrou; Brian F Hutton; Irfan Kayani; Nicholas J Screaton; Joanna C Porter; Toby M Maher; Raymondo Endozo; Robert I Shortman; Pauline Lukey; Ashley M Groves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-30       Impact factor: 9.236

6.  PET/CT and interstitial lung disease.

Authors:  Marcio Valente Yamada Sawamura; Ronaldo Adib Kairalla; Carlos Alberto Buchpigel
Journal:  J Bras Pneumol       Date:  2022-09-05       Impact factor: 2.800

7.  [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity.

Authors:  Zachary T Rosenkrans; Christopher F Massey; Ksenija Bernau; Carolina A Ferreira; Justin J Jeffery; Jefree J Schulte; Melissa Moore; Frank Valla; Jeanine M Batterton; Christopher R Drake; Alan B McMillan; Nathan Sandbo; Ali Pirasteh; Reinier Hernandez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-12       Impact factor: 10.057

8.  Apoptotic PET Imaging of Rat Pulmonary Fibrosis with Small-Molecule Radiotracer.

Authors:  Ying Xiong; Dahong Nie; Shaoyu Liu; Hui Ma; Shu Su; Aixia Sun; Jing Zhao; Zhanwen Zhang; Xianhong Xiang; Ganghua Tang
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

9.  Fluro-deoxygenase-positron emission tomography/computed tomography in hard metal lung disease.

Authors:  Kapil Iyer; Vinaya Karkhanis; Sandip Basu; Jyotsna M Joshi
Journal:  Lung India       Date:  2015 Sep-Oct

10.  Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.

Authors:  Thida Win; Benjamin A Thomas; Tryphon Lambrou; Brian F Hutton; Nicholas J Screaton; Joanna C Porter; Toby M Maher; Raymondo Endozo; Robert I Shortman; Asim Afaq; Pauline Lukey; Peter J Ell; Ashley M Groves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.